Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision history now shows new August 2026 entries and Revision: v3.6.6. The older July 2026 entries and Revision: v3.6.5 are no longer listed.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded the line 2023 ( U.S. NIH Grant/Contract ) in the study's funding information. This identifies the NIH as a funder for the year 2023, providing transparency about support for the trial.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page shows Revision: v3.6.5, replacing v3.6.4. This indicates a backend or CMS update rather than a change to study details or visible content.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now states that recruitment is closed with the note 'No longer looking for participants', and associated recruitment prompts and contact details have been removed. This reflects that the study is not actively enrolling at this time.SummaryDifference2%

- Check47 days agoChange DetectedThe page now displays 'Bladder cancer' and a related topics section linking to MedlinePlus Genetics, providing disease context and educational resources alongside the study information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows Revision: v3.6.4 instead of v3.6.3, representing a deployment update to the site; no substantive study-content changes are reflected.SummaryDifference0.0%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.